Fortive Corp Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD from Q4 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
Fortive Corp quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and growth rate from Q4 2015 to Q3 2024.
  • Fortive Corp Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending September 27, 2024 was $10.6B, a 4.74% increase year-over-year.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $10.6B +$478M +4.74% Sep 27, 2024 10-Q 2024-10-30
Q2 2024 $10.5B +$534M +5.36% Jun 28, 2024 10-Q 2024-07-24
Q1 2024 $10.5B +$607M +6.15% Mar 29, 2024 10-Q 2024-04-24
Q4 2023 $10.3B +$637M +6.57% Dec 31, 2023 10-Q 2024-10-30
Q3 2023 $10.1B +$688M +7.32% Sep 29, 2023 10-Q 2023-10-25
Q2 2023 $9.97B +$522M +5.53% Jun 30, 2023 10-Q 2023-07-26
Q1 2023 $9.88B +$309M +3.23% Mar 31, 2023 10-Q 2023-04-26
Q4 2022 $9.69B +$172M +1.8% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $9.4B +$72.9M +0.78% Sep 30, 2022 10-Q 2022-10-26
Q2 2022 $9.45B +$240M +2.6% Jul 1, 2022 10-Q 2022-07-28
Q1 2022 $9.57B +$550M +6.1% Apr 1, 2022 10-Q 2022-04-28
Q4 2021 $9.52B +$544M +6.07% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $9.32B +$1.63B +21.3% Oct 1, 2021 10-Q 2021-10-28
Q2 2021 $9.21B +$1.8B +24.3% Jul 2, 2021 10-Q 2021-07-29
Q1 2021 $9.02B +$1.76B +24.3% Apr 2, 2021 10-Q 2021-04-29
Q4 2020 $8.97B +$1.57B +21.2% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $7.69B +$525M +7.32% Sep 25, 2020 10-Q 2020-10-27
Q2 2020 $7.41B +$384M +5.47% Jun 26, 2020 10-Q 2020-07-28
Q1 2020 $7.25B +$391M +5.69% Mar 27, 2020 10-Q 2020-04-30
Q4 2019 $7.4B +$787M +11.9% Dec 31, 2019 10-K 2021-02-26
Q3 2019 $7.16B +$1.31B +22.5% Sep 27, 2019 10-Q 2019-10-25
Q2 2019 $7.02B +$1.38B +24.5% Jun 28, 2019 10-Q 2019-07-25
Q1 2019 $6.86B +$2.75B +67% Mar 29, 2019 10-Q 2019-04-25
Q4 2018 $6.61B +$2.8B +73.6% Dec 31, 2018 10-K 2020-02-27
Q3 2018 $5.85B +$2.37B +68.2% Sep 28, 2018 10-Q 2018-10-25
Q2 2018 $5.64B +$2.47B +77.8% Jun 29, 2018 10-Q 2018-07-26
Q1 2018 $4.11B +$1.22B +42.1% Mar 30, 2018 10-Q 2018-04-26
Q4 2017 $3.81B +$1.12B +41.5% Dec 31, 2017 10-K 2019-02-28
Q3 2017 $3.48B +$919M +35.9% Sep 29, 2017 10-Q 2017-10-26
Q2 2017 $3.17B +$801M +33.7% Jun 30, 2017 10-Q 2017-07-27
Q1 2017 $2.89B Mar 31, 2017 10-Q 2017-04-27
Q4 2016 $2.69B -$2.49B -48.1% Dec 31, 2016 10-K 2018-02-28
Q3 2016 $2.56B Sep 30, 2016 10-Q 2016-10-27
Q2 2016 $2.37B Jul 1, 2016 10-Q 2016-08-02
Q4 2015 $5.18B Dec 31, 2015 10-K 2017-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.